Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC

Aberrant expression of epithelial and neuroendocrine markers is rare in diffuse large B‐cell lymphoma (DLBCL) and can lead to erroneous diagnosis with inappropriate treatment. This case report describes a case of DLBCL with a co‐expression of cytokeratins and CD56 that was misdiagnosed as metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Prevodnik, Veronika Kloboves, Gašljević, Gorana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108145/
https://www.ncbi.nlm.nih.gov/pubmed/36336889
http://dx.doi.org/10.1111/cyt.13190
_version_ 1785026788371464192
author Prevodnik, Veronika Kloboves
Gašljević, Gorana
author_facet Prevodnik, Veronika Kloboves
Gašljević, Gorana
author_sort Prevodnik, Veronika Kloboves
collection PubMed
description Aberrant expression of epithelial and neuroendocrine markers is rare in diffuse large B‐cell lymphoma (DLBCL) and can lead to erroneous diagnosis with inappropriate treatment. This case report describes a case of DLBCL with a co‐expression of cytokeratins and CD56 that was misdiagnosed as metastatic neuroendocrine carcinoma.[Image: see text]
format Online
Article
Text
id pubmed-10108145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101081452023-04-18 Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC Prevodnik, Veronika Kloboves Gašljević, Gorana Cytopathology Case Reports Aberrant expression of epithelial and neuroendocrine markers is rare in diffuse large B‐cell lymphoma (DLBCL) and can lead to erroneous diagnosis with inappropriate treatment. This case report describes a case of DLBCL with a co‐expression of cytokeratins and CD56 that was misdiagnosed as metastatic neuroendocrine carcinoma.[Image: see text] John Wiley and Sons Inc. 2022-12-07 2023-03 /pmc/articles/PMC10108145/ /pubmed/36336889 http://dx.doi.org/10.1111/cyt.13190 Text en © 2022 The Authors. Cytopathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Prevodnik, Veronika Kloboves
Gašljević, Gorana
Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title_full Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title_fullStr Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title_full_unstemmed Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title_short Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
title_sort cytokeratin and cd56 aberrant co‐expression in diffuse large b‐cell lymphoma, nos misinterpreted as metastatic neuroendocrine carcinoma by fnac
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108145/
https://www.ncbi.nlm.nih.gov/pubmed/36336889
http://dx.doi.org/10.1111/cyt.13190
work_keys_str_mv AT prevodnikveronikakloboves cytokeratinandcd56aberrantcoexpressionindiffuselargebcelllymphomanosmisinterpretedasmetastaticneuroendocrinecarcinomabyfnac
AT gasljevicgorana cytokeratinandcd56aberrantcoexpressionindiffuselargebcelllymphomanosmisinterpretedasmetastaticneuroendocrinecarcinomabyfnac

Ejemplares similares